Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

MCR-1 thought to be 'circulating' in the US
pig
MCR-1 was first discovered in multiple samples from pigs, pork and humans in China late last year.(stock photo)
Second pig sample found to contain colistin-resistant bacteria
 
US health officials have found bacteria that is resistant to the 'last resort' antibiotic, colistin, in a second pig sample. A similar discovery was made last month in a human patient.

Experts say there is growing evidence that the MCR-1 gene - which allows bacteria to become resistant to colistin - is circulating in the US. It is feared the gene could spread to bacteria that can only be treated with colistin, creating a superbug that is immune to all available antibiotics.

The latest discovery was made during testing at a slaughterhouse in Illinois, according to the Washington Post. E.coli bacteria carrying the gene was identified in a pig intestine, a spokeswoman for the US Department of Agriculture is reported to have said.

This is the second pig sample in the US found to contain resistant bacteria. A different strain of E.coli carrying MCR-1 was discovered in the intestines of a pig from another state last month.

For the first time, MCR-1 was also detected in a human patient in the US. E.coli bacteria carrying the gene was identified in a urine sample from the 49-year-old Pennsylvania resident.

Patrick McGann from the US Department of Defense, is quoted by the Washington Post as saying: "Mounting evidence suggests the MCR-1 gene is circulating within the United States. Our sample was in a woman with no recent travel history, the pig samples are from slaughterhouses in the USA, and [the] strains are all different."

Scientists across the globe have been looking for the gene since it was first discovered in multiple samples from pigs, pork and humans in China late last year.

Colistin is one of the last resort drugs, used to treat bacteria that is resistant to other antibiotics. The concern is that MCR-1 exists on a plasmid - a small piece of DNA - that can move from one bacterium to another, spreading antibiotic resistance. The gene has since been found in Europe and Canada, as well as the US.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.